SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-12-000277
Filing Date
2012-04-20
Accepted
2012-04-20 10:07:02
Documents
7
Period of Report
2012-04-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR APRIL 20, 2012 nymox6kmpm120419.htm 6-K 4777
2 NOTICE OF ANNUAL GENERAL MEETING AND MANAGEMENT PROXY CIRCULAR exhibit99-1.htm EX-99.1 135764
3 FORM OF PROXY exhibit99-2.htm EX-99.2 23687
4 exhibit99-1x7x1.jpg GRAPHIC 65204
5 nymoxlogo.jpg GRAPHIC 5145
6 computersharelogo.jpg GRAPHIC 2067
7 exhibit99-2x1x1.jpg GRAPHIC 3257
  Complete submission text file 0001176256-12-000277.txt   270046
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 12769778
SIC: 2835 In Vitro & In Vivo Diagnostic Substances